Clinical trials for Crohn's disease investigate a range of treatment strategies and patient populations.

30 total trials for this combination

Showing top 10 of 30 trials

Trials

NCT ID	Title	Status	Phase
NCT03104413	A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment	COMPLETED	PHASE3
NCT00771667	A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy	COMPLETED	PHASE2
NCT03345849	A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies	COMPLETED	PHASE3
NCT03926130	A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	COMPLETED	PHASE3
NCT03105128	A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease	COMPLETED	PHASE3
NCT03345836	A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy	COMPLETED	PHASE3
NCT02914561	Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease	COMPLETED	PHASE3
NCT02914600	Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease	TERMINATED	PHASE3
NCT03345823	A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433	ACTIVE_NOT_RECRUITING	PHASE3
NCT03105102	A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease	ACTIVE_NOT_RECRUITING	PHASE3

Related Pages

All Crohn's disease trials All trials in Beersheba, Israel